Gossamer Bio (GOSS) Cash on Hand
Market Cap: $188.57M
Avg Volume: 1.53M
Industry: Biotechnology
Sector: Healthcare
How much cash does Gossamer Bio have?
According to Gossamer Bio's latest annual financial reports, the company has a total of $46.07M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.
Additionally, Gossamer Bio holds $248.44M in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.
In total, the company has $294.52M when combining cash and cash equivalents with short-term investments.
On a per-share basis, Gossamer Bio has $1.30 in cash. This metric helps investors understand how much cash the company holds per outstanding share.
The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-3.47M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.
Lastly, the company's cash position has experienced a growth rate of 43.49%, reflecting the increase in cash and cash equivalents over the specified period.
Cash & Cash Equivalents
$46.07M
Short-Term Investments
$248.44M
Cash & Short-Term Investments
$294.52M
Cash Per Share
$1.30
Free Cash Flow
$-3.47M
Cash Growth
43.49%
Gossamer Bio Historical Cash on Hand
Cash on Hand History
The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2024.
| Year | Cash on Hand | Change |
|---|---|---|
| 2024 | $46.07M | 43.49% |
| 2023 | $32.11M | -71.32% |
| 2022 | $111.97M | -38.95% |
| 2021 | $183.40M | -62.27% |
| 2020 | $486.06M | 259.80% |
| 2019 | $135.09M | 28.39% |
| 2018 | $105.22M | 33302.86% |
| 2017 | $315.00K | 425.00% |
| 2016 | $60.00K | N/A |
Related Metrics
Explore detailed financial metrics and analysis for GOSS.